AteÅŸ, Ã., Nomak, G., Orer, H. S., Åžentürk, R. S., Altuntas, F., Nomak, H. S., Sanyal, R. (2025). Phase 1a dose-escalation study of RS-0139: A novel tumor-targeted nanomedicine for advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e15006